Lincoln National Corp’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-2,004
| Closed | -$793K | – | 1135 |
|
2024
Q1 | $793K | Sell |
2,004
-110
| -5% | -$43.5K | 0.01% | 590 |
|
2023
Q4 | $744K | Buy |
2,114
+310
| +17% | +$109K | 0.01% | 541 |
|
2023
Q3 | $677K | Buy |
1,804
+64
| +4% | +$24K | 0.01% | 503 |
|
2023
Q2 | $666K | Sell |
1,740
-72
| -4% | -$27.5K | 0.01% | 505 |
|
2023
Q1 | $628K | Buy |
1,812
+66
| +4% | +$22.9K | 0.01% | 511 |
|
2022
Q4 | $411K | Buy |
1,746
+22
| +1% | +$5.18K | 0.01% | 595 |
|
2022
Q3 | $424K | Buy |
1,724
+464
| +37% | +$114K | 0.01% | 541 |
|
2022
Q2 | $381K | Buy |
1,260
+132
| +12% | +$39.9K | 0.01% | 562 |
|
2022
Q1 | $463K | Buy |
1,128
+254
| +29% | +$104K | 0.01% | 556 |
|
2021
Q4 | $410K | Hold |
874
| – | – | 0.01% | 597 |
|
2021
Q3 | $371K | Buy |
874
+253
| +41% | +$107K | 0.01% | 602 |
|
2021
Q2 | $223K | Buy |
+621
| New | +$223K | ﹤0.01% | 772 |
|